Muscle development involves coordinated molecular events leading to cell proliferation, fusion, differentiation, sarcomere assembly, and myofibrogenesis. However, under physiological or pathological stress, energy requirements and secretion of glucocorticoids increase, resulting in muscle atrophy because of the depletion of energy reserves. Glucocorticoids induce muscular atrophy by two main mechanisms, protein degradation through the ubiquitin-proteasome system, and inhibition of protein synthesis through the negative regulation of the IGF1-Akt-mTOR signaling pathway. Other signaling pathways (such as the myostatin-activin-smad pathway) involved in muscle atrophy by glucocorticoid exposure are unclear. In fish, the role of glucocorticoids in muscle atrophy has not been fully elucidated. The aim of the present study was to evaluate the mechanisms of muscle atrophy induced by a synthetic glucocorticoid (dexamethasone, DEX) in an ex vivo muscle culture system of a marine fish (Lutjanus guttatus). Results showed that DEX was able to induce the expression of myostatin-1, and the expression of the transcription factor foxo3b. Myostatin-1 silencing by RNAi produced a decrease in the expression of foxo3b and murf1, and increased the expression of mtor, myod-2 and myogenin. These results suggest that in fish skeletal muscle, myostatin-1 signaling participates in glucocorticoid-induced muscle wasting through the negative regulation of genes involved in muscle growth, such as mtor, myod-2 and myogenin, and the induction of atrophy genes like foxo3b and murf1.
Introduction
Fish in culture are exposed to stressful situations such as temperature and salinity changes, overcrowding conditions, low water quality, diseases, and handling, affecting growth performance (Galt et al., 2016) . Under stressful conditions, the pituitary gland releases adrenocorticotropic hormone (ACTH), which regulates the release of cortisol (which is the main glucocorticoid steroid) by the adrenal gland to mobilize energetic reserves (Barcellos et al., 2010; Bodine and Furlow, 2015; Braun and Marks, 2015) . Skeletal muscle is a major target of glucocorticoids because it is an important source of proteins, and constitutes 40 to 60% of the body mass (Johnston et al., 2011; Bodine and Furlow, 2015) ; it is an energy source for other organs such as heart, liver, and brain (Bonaldo and Sandri, 2013; Braun and Marks, 2015) .
Glucocorticoids (GCs) are important for the maintenance of glucose homeostasis, they regulate the metabolism and mobilization of carbohydrates, lipids, and proteins under stressful physiological or pathological conditions (Granner et al., 2015; Bodine and Furlow, 2015; Braun and Marks, 2015) . The GC receptor (GR) is expressed at higher levels in fast-twitch (glycolytic) muscle fibers; therefore, in the presence of high concentrations of GCs, the skeletal muscle suffers proteolysis and catabolic processes to increase the availability of free amino acids, and to promote gluconeogenesis. Under sustained exposure to GCs, muscle atrophy could occur through a decrease in protein synthesis and an increase in protein degradation (Bodine and Furlow, 2015) , showing a reduction in cell size with loss of cellular contents (organelles, cytoplasm, and proteins) (Bonaldo and Sandri, 2013; Braun and Marks, 2015) .
Protein degradation occurs mainly through the ubiquitin-proteasome system to remove sarcomeric proteins. Although not all of the ubiquitin ligases participating in skeletal muscle atrophy are known, two important ligases have been identified, atrogin-1 (also known as MAFbx, Muscle Atrophy F-box), and MuRF1 (Muscle Specific Ring Finger Protein 1); both ligases recognize different substrates in skeletal muscle (Bonaldo and Sandri, 2013; Braun and Marks, 2015) ; while MuRF1 contains GC response elements (GRE) in the promoter region, atrogin-1 is activated indirectly, through the forkhead domain-containing class O transcription factors (FoxOs) (Bodine and Furlow, 2015) . Members of the FoxO family, such as FoxO 1, 3, and 4 are also directly induced by GCs in skeletal muscle, they mediate insulin action, the regulation of metabolic enzymes, the response to oxidative stress, and autophagy. They participate in skeletal muscle atrophy by regulating the expression of Murf1 and Atrogin-1 (Bodine and Furlow, 2015) , and in the inhibition of protein synthesis by suppressing the regulator-associated protein of mTOR (Raptor) to reduce the growthpromoting activity of mTOR complex 1 (TORC1) with no effect on TORC2 (Morris et al., 2015) .
Another player in GC-induced skeletal muscle atrophy is myostatin, which is an important negative regulator of muscle growth (McPherron et al., 1997) . In mammals, evidence connecting GC-dependent muscle atrophy and myostatin exists because of the presence of GREs in the myostatin promoter (Ma et al., 2001; Ma et al., 2003; Gilson et al., 2007; Schakman et al., 2008; Bodine and Furlow, 2015) . In addition, it has been reported that myostatin activates MurF1 and Atrogin-1 (McFarlane et al., 2006) and decreases activity of the Akt/TORC1/ p70S6K signaling pathway (Trendelenburg et al., 2009) . In fish however, information is still unclear. For instance, the rainbow trout (Oncorhynchus mykiss) does not contain GREs in the promoter region of the four mstn paralogues (Garikipati et al., 2006; Garikipati et al., 2007) , but different concentrations of cortisol showed a non-monotonic behavior of mstn-1b expression in myoblast primary cultures after 24 h, with no significant changes in mstn-1a, and mstn-2a (Galt et al., 2014) . In addition, it has been reported that in barramundi (Lates calcarifer), fasting-related stress increased myostatin expression in a tissue-specific manner, particularly in the skeletal muscle (De Santis and Jerry, 2011) .
Thus, to better understand the mechanisms by which GCs induce muscle atrophy in fish, and the role of myostatin in this process, we used an ex vivo muscle tissue system from a marine cultured fish (spotted rose snapper, Lutjanus guttatus) to evaluate the effects of a synthetic glucocorticoid (dexamethasone, DEX) in myostatin-1 (mstn-1) expression. We also measured the expression of growth and atrophyrelated genes in DEX-exposed muscle tissue, followed by post-transcriptional silencing of mstn-1 to understand the cross-communication between myostatin and growth/atrophy genes under glucocorticoidinduced cellular stress.
Results

DEX exposure induced mstn-1 expression in skeletal muscle ex vivo
In a first approach, we exposed muscle tissue under ex vivo culture conditions to 50 and 100 nM DEX for 24, 48, and 72 h, and measured mstn-1 expression (the procedure to prepare the ex vivo muscle culture is explained in the Experimental procedures, Section 4.1). The results showed that the expression of mstn-1 increased in skeletal muscle tissue at 48 h after treatment with DEX, showing maximum expression levels at 72 h post-exposure to both 50 and 100 nM DEX. Since this was a preliminary experiment with duplicated samples, statistics were not performed; nevertheless, no evident differences were observed between both concentrations of DEX at 48 and 72 h ( Fig. 1 ).
mstn-1 expression and post-transcriptional silencing in DEX-treated muscle tissues
Skeletal muscle tissue was exposed to 50 nM DEX from experimental day 1 to day 4 (see Experimental Procedures, Section 4.2) to induce mstn-1 expression according to preliminary results (see Section 2.1). Expression of mstn-1 was induced as expected at day 4 ( Fig. 2 , left panel, BLANK-2 compared to BLANK-1), and still detected at day 7, 3 days after DEX was removed from the culture media (see Experimental Procedures, Section 4.2) ( Fig. 2 , right panel, BLANK-2 compared to BLANK-1). Silencing of mstn-1 was detected in DEX-exposed muscle tissues at day 4 ( Fig. 2, left panel) , and in DEX-free tissues at day 7 ( Fig. 2, right panel) . The expression of mstn-1 in muscle tissues transfected with scRNA showed some variations; expression levels were not significantly different from the control treated with DEX (BLANK-2), they were significantly different from samples transfected with dsiRNA-mstn1 at day 4 but not at day 7. These variations could be due to individual responses among replicates to non-specific effects of transfection in this experimental system. The exact causes are difficult to define at this time and need a more detailed analysis.
2.3. mstn-1 negatively modulates the expression of growth-related genes in the presence of DEX DEX treatment did not significantly change the expression of mtor and muscle regulatory factors (myod-1, myod-2, myogenin, and mrf4) at day 4 ( Fig. 3 , left panel, BLANK-1 and BLANK-2) or day 7 ( Fig. 3 , right panel, BLANK-2 compared to BLANK-1). The lack of statistical significance at day 4 could be due to the variation among samples, together with a small sample size (n = 4). Nevertheless, mstn-1 silencing strongly induced the expression of two muscle regulatory factors, myod-2 and myogenin, and, in a lesser extent mtor, in the presence of DEX at day 4 ( Fig. 3 , left panel). These genes showed significant differences in expression levels, and significant correlations among them, together with negative correlations with mstn-1 (Table 1 ). The effect was lost at day 7, when DEX was removed from the culture medium, even if mstn-1 was still silenced ( Fig. 3 , right panel) suggesting that other mechanisms (independent from mstn-1 signaling) restored gene expression levels when DEX was not longer present. Interestingly, myod-2 was more responsive to mstn-1 silencing than myod-1, and the correlation between the expression of myod-2 and myogenin was higher than with myod-1 (Table 1 ). The results suggest that mstn-1 signaling negatively modulates the expression of mtor, myod-2, and myogenin, regulating muscle growth in the presence of DEX. As with mstn-1 expression, the expression of mtor and myogenic genes showed some variations in tissues transfected with the scRNA sequence in the presence of DEX at day 4, suggesting non-specific effects of transfection in this experimental system which, at this point, are difficult to define.
mstn-1 modulates the expression of atrophy genes in DEX-treated skeletal muscle
Atrophy genes tested in this experiment were foxo3a, foxo3b, murf1, and atrogin-1. Expression of foxo3a and atrogin-1 was barely detected, therefore these two genes were not considered for further analysis. Expression levels of foxo3b and murf1 did not significantly change in muscle tissues treated with DEX at day 4 ( Fig. 4 , left panel, BLANK-2 compared to BLANK-1), however, expression of foxo3b (but not murf1) significantly increased at day 7 ( Fig. 4 , right panel, BLANK-2 compared to BLANK-1). These results suggest that DEX-induced muscle atrophy involves Foxo3b signaling in a late response. Silencing of mstn-1 decreased the expression of foxo3b at day 4 and day 7, and the expression of murf1 at day 7 ( Fig. 4) . Correlation between mstn-1 and foxo3b expression was significant (Table 1 ), suggesting a cross-talk between mstn-1 and foxo3b signaling pathways. In this case, expression of atrophy genes showed no effects to the transfection with the scRNA sequence.
Discussion
A relation between GC-induced skeletal muscle atrophy and mstn expression has been reported in mammalian (in vivo and in vitro) systems (Ma et al., 2001; Ma et al., 2003; Gilson et al., 2007; Wang et al., 2016) , while in fish the role of mstn in this process is not clear. Contrary to mammals, fish possess two to four mstn paralogues (due to genome duplication events during fish evolution, L. guttatus possess two paralogues), which are expressed in different tissues (Torres-Velarde et al., 2015), and their functions in GC-induced muscle atrophy in both skeletal muscle and non-muscle tissues have not been fully elucidated (Galt et al., 2014; Galt et al., 2016) . For example, the rainbow trout possess four mstn paralogues, and none of them contain GREs in their promoters (Garikipati et al., 2006; Garikipati et al., 2007) . Nevertheless, exposure of rainbow trout myoblasts for 24 h to different concentrations (10,100, 1000 ng mL −1 ) of cortisol did not increase expression of mstn-1a and 2a, however, the expression of mstn-1b showed a non-monotonic behavior, increasing from 10 to 100 ng mL −1 , and then decreasing at 1000 ng mL −1 (Galt et al., 2014) . These results suggest an indirect regulation of cortisol on mstn-1b expression in this species. On the other hand, fasting-induced stress in barramundi L. calcarifer resulted in an increase of mstn-1 expression in skeletal muscle and liver, and a decrease in brain and gills; mstn-2 however showed a very different behavior, increasing in gills and liver, with no significant changes in skeletal muscle and brain, suggesting different upstream regulatory regions for both paralogues (De Santis and Jerry, 2011).
According to Bodine and Furlow (2015) , the activation of the GR by GCs would result in the modulation of the expression of many different genes in the skeletal muscle, with variations dependent on several factors, such as the type of GC (natural or synthetic), the dose or concentration, the exposure time, the experimental system (in vitro or in vivo) and the species. For instance, Wang et al. (2016) exposed C2C12 murine skeletal myoblasts to 100 μM DEX with and without 800 ng mL −1 follistatin for 12, 24, 36, and 48 h, to understand the role of myostatin in GC-induced catabolism. The authors found a decrease in protein synthesis and an increase of myostatin expression in DEX-treated cells after 36 h, but no significant differences were detected at 24 and 48 h. Important differences in both experimental systems are noted, we used a lower concentration of DEX (50 nM vs 100 μM), and our experimental system was skeletal muscle tissue from fish, as compared to murine skeletal myoblasts. Therefore, their results are only partially consistent with our study, since mstn-1 expression was significantly induced with a very low concentration of DEX (50 nM) at 72 h postexposure (day 4), and the expression was maintained for 7 days, even if DEX was removed from the culture medium.
On the other hand, expression of mtor and muscle regulatory factors (myod-1, myod-2, myogenin, and mrf4) at day 4 did not show significant changes in the presence of DEX, and no effect was observed after DEX was removed. In a previous study, Sun et al. (2008) reported that degradation of MyoD in C2C12 skeletal myoblasts in the presence of GCs depends on the differentiation stage of the cells (myoblasts or myotubes); this is important because most studies regarding the role of muscle regulatory factors in the presence of GCs are performed in vitro with undifferentiated myoblasts, while in vivo (or ex vivo) the studies are performed with differentiated myofibers and myotubes. These features may account for the variations observed in different studies. Wang et al. (2016) also reported that DEX up-regulated transcription of foxo1, murf1, and atrogin-1, while foxo3 did not show significant Effect of DEX and dsiRNA-mstn1 in mstn-1 expression by qPCR. +DEX indicates that 50 nM DEX was added to the culture medium. −DEX indicates that DEX was retired from the culture medium. Blank-1 indicates that DEX was never added to the culture medium. Blank-2 indicates that DEX was added to the culture medium, and then retired. dsiRNA-mstn1 indicates that tissues were transfected with dsiRNA to silence mstn-1. scRNA indicates that tissues were transfected with a scrambled sequence. Different letters indicate significant differences in gene expression. Left panel shows results at day 4 and right panel shows results at day 7. Each treatment was performed with four replicates; expression values were normalized against the geometric mean of gapdh and β-actin.
changes, and that follistatin significantly decreased the activation of FoxO1/3a and MuRF1, with no significant changes in Atrogin-1. These results are in general consistent with our observations, however we did not observe significant differences of foxo3b and murf1 expression at 72 h of exposure to DEX (day 4), although foxo3b showed a late response at day 7. Instead of myostatin inactivation by follistatin, we used an RNAi approach to post-transcriptionally silence mstn-1, resulting in a decrease of murf1 and mostly of foxo3b expression in the presence of DEX at day 4, lasting to day 7. Also, expression of mtor and two myogenic factors (myod-2 and myogenin) showed a significant Fig. 3 . Effect of dexamethasone (DEX) and dsiRNA-mstn1 in the expression of mtor, myod-1, myod-2, myogenin, and mrf4. +DEX indicates that 50 nM DEX was added to the culture medium. −DEX indicates that DEX was retired from the culture medium. Blank-1 indicates that DEX was never added to the culture medium. Blank-2 indicates that DEX was added to the culture medium, and then retired. dsiRNA-mstn1 indicates that tissues were transfected with dsiRNA to silence mstn-1. scRNA indicates that tissues were transfected with a scrambled sequence. Left panel shows results at day 4 and right panel shows results at day 7. Different letters indicate significant differences in gene expression (relative to gapdh and β-actin geomean). No letters indicate that significant differences were not detected in any treatment. increase at day 4 but not at day 7. In addition, correlation analysis revealed a significant association between mstn-1 and foxo3b, suggesting some crosstalk between the two signaling pathways. Some studies have demonstrated that the absence of myostatin prevents GC-induced atrophy. For instance, mstn-mutant mice receiving an intramuscular injection of DEX did not show muscle wasting, and expression of atrogin-1, murf1, and foxo3a remained unchanged (Gilson et al., 2007) . Similarly, mice treated with DEX and RU486 (a GC antagonist) did not show mstn induction, and skeletal muscle atrophy was attenuated (Ma et al., 2003) .
It has been documented that FoxO3 and Smad3 (Small Mothers Against Decapentaplegic, a transcription factor activated in the myostatin pathway) synergistically activate transcription and promoter activity of murf1 in primary human skeletal muscle myoblasts (Smad3/ FoxO3 transcriptional complex); Smad3 increases FoxO3 binding at a conserved FoxO responsive element (FRE)-Smad responsive element (SRE) motif in the proximal promoter of murF1 (Bollinger et al., 2014) . Moreover, Smad3 (through the decrease of miR-29) was sufficient to inhibit mTOR signaling in vivo (Goodman et al., 2013) , but was not able to induce Foxo3 transcription in vitro (Bollinger et al., 2014) .
Nevertheless, it has been reported that FoxO3 is able to inhibit protein synthesis by suppressing the regulator-associated protein of mTOR (Raptor) reducing TORC1 activity (Morris et al., 2015) . In addition, it has been shown that myostatin is capable of inhibiting myoblast differentiation by repressing MyoD transcription through Smad3 in vitro (Langley et al., 2002) , and protein synthesis by blocking Akt through two different signaling pathways. The first involves Smad/Akt/ mTOR, since Akt activity decreases in the presence of myostatin in both myoblasts and myotubes, and Smad2 increases when Raptor is blocked (Morissette et al., 2009; Trendelenburg et al., 2009 ). The second pathway involves Activin receptor IIB/PI3K/Akt signaling, independent from Smad3, arresting the cell cycle in G1 (Yang et al., 2007) .
We observed a significant increment in the expression levels of mtor, myod-2 and myogenin in DEX-treated skeletal muscle tissue in which mstn-1 had been silenced, suggesting that mstn-1 signaling negatively regulates mtor, myod-2, and myogenin expression (probably through the Smad/FoxO3b complex) in the presence of glucocorticoids in an early response. Interestingly, in rainbow trout, in a fasting-refeeding experiment, the expression of myogenin and myod-2 increased after refeeding, when fish were no longer under fasting stress (Johansen and Overturf, 2006) . The myogenic gene myod-2 is a paralogue of myod-1 in fish, and its function has not been completely elucidated, therefore further research is necessary to understand Myod-2 function in skeletal muscle development and growth.
In conclusion, the ex vivo culture system for skeletal muscle from L. guttatus allowed the study of GC-induced gene expression and mstn-1 silencing to describe some mechanisms of stress-related muscle atrophy, and the role mstn-1 plays in this catabolic process. The results suggest that in L. guttatus, mstn-1 signaling in the presence of GCs is implicated in the negative regulation of muscle growth by downregulating mtor, myod-2 and myogenin expression in skeletal muscle, most likely through the formation of the Smad/FoxO3 complex and/or Smad2, followed by the transcriptional activation of atrophy genes (such as murf1). So far, to our knowledge, there is no evidence indicating that Smads activate foxo3b expression, therefore the mechanisms by which mstn-1 and foxo3b are transcriptionally co-regulated as observed in this study deserves further investigation (Fig. 5 ).
Experimental procedures
Ex vivo skeletal muscle culture
Fish were collected and treated according to Torres-Velarde et al. (2016) . Briefly, fish (~100 g body weight) were collected from growout ponds. For muscle sampling, fish were anaesthetized by an overdose of tricaine methanesulfonate MS 222 according to Galaviz et al. (2012) , cleaned by dipping in sterile water for 1 min followed by 1% sodium hypochlorite, and wiped with 70% alcohol for 1 min. The skin from the flank of each fish below the lateral line and viscera was carefully removed and discarded using a sterile scalpel blade. The dorsal muscle was dissected under aseptic conditions in a laminar flow cabinet, and placed in petri dishes with DMEM culture medium (Gibco), containing FBS 15% (v/v), penicillin/streptomycin 1% (v/v), Fungizone™ 1% (v/ v), glutamine 1% (v/v), and gentamycin 75 IU, according to Torres-Velarde et al. (2016) . Subsequently, the muscle was cut into small pieces (approximately 4 × 4 × 2 mm) using a sterile surgical scalpel in the same solution. Tissue fragments were gently transferred onto floating membrane discs (13 mm Omnipore™ membrane filters; 0.45 μm pore size; Millipore) over 600 μl of conditioned DMEM medium (Gibco). Muscles were acclimatized for 24 h at 29°C prior exposure to dexamethasone (DEX) in a 5% CO 2 atmosphere at 80% humidity. Fig. 4 . Effect of dexamethasone (DEX) and dsiRNA-mstn1 in the expression of foxo3b and murf1. +DEX indicates that 50 nM DEX was added to the culture medium. −DEX indicates that DEX was retired from the culture medium. Blank-1 indicates that DEX was never added to the culture medium. Blank-2 indicates that DEX was added to the culture medium, and then retired. dsiRNA-mstn1 indicates that tissues were transfected with dsiRNA to silence mstn-1. scRNA indicates that tissues were transfected with a scrambled sequence. Left panel shows results at day 4 and right panel shows results at day 7. Different letters indicate significant differences in gene expression (relative to gapdh and β-actin geomean). No letters indicate that significant differences were not detected in any treatment.
Dexamethasone exposure and mstn-1 gene silencing experiments
To know if DEX exposure would have an effect in mstn-1 expression, we performed a preliminary experiment in which skeletal muscle tissue was exposed to two different DEX concentrations (50 and 100 nM) according to previous reports (Qin et al., 2013; Belanto et al., 2010) during 24, 48, and 72 h. Duplicated samples were collected and preserved in RNAlater (Thermo Fisher Scientific) to isolate RNA and assess gene expression by end point and real-time PCR.
A second experiment was performed to silence mstn-1 in DEXtreated muscle tissues. dsiRNAs (including the scRNA sequence) were designed according to the protocol from Integrated DNA Technologies (IDT, http://www.idtdna.com/pages/products/gene-silencing/customdsirna) to target exon 3 of the myostatin transcript from L. guttatus (GenBank: JX987064) encoding the active peptide domain. The experiment was performed in skeletal muscle tissue ex vivo in four replicates for 7 days. The timeline was as follows: At day 0 the ex vivo experimental system was set up. At day 1, DEX was added to the culture medium in a concentration of 50 nM. At day 2, tissues were transfected either with dsiRNA-mstn1 or scRNA (300 pmol according to previous studies, see Sifuentes-Romero et al., 2013 and Torres-Velarde et al., 2016) using XFect™ reagent (Clontech). At day 4 samples were taken for gene expression analysis; at this point DEX was removed from the remaining samples to evaluate the lasting effect. Finally, at day 7, gene expression was measured again. Muscle samples were collected in RNAlater to isolate RNA and assess gene expression by real-time PCR.
RNA extraction and real-time PCR
Total RNA extraction was performed with TRIzol reagent (Invitrogen), following the manufacturer's instructions. RNA was digested with DNAse-I (Promega) to remove genomic DNA contamination prior to cDNA synthesis, which was performed with MMLV reverse transcriptase (Promega) in the presence of random primers (Promega). Gene-specific primers were designed for all genes tested (Table 2) using the Primer3 software (Rozen and Skaletsky, 2000) . Real-time PCR reactions were carried out in a CFX96 thermal cycler (Bio-Rad), with the Luna® Universal qPCR Mastermix (New England Biolabs) under the following conditions: 95°C 30 s 1 cycle, then 40 cycles at 95°C 20 s, 60°C 20 s. Gene expression was estimated with the comparative ΔCT method according to Livak and Schmittgen (2001) using the geometric mean of two reference genes (β-actin and gapdh). The stability of these reference genes for muscle development was evaluated in previous studies (Torres-Velarde et al., 2015; Escalante-Rojas et al., 2018) with the geNorm algorithm (Vandesompele et al., 2002) through the qbase+ software v3.1 (www.qbaseplus.com).
Statistical analysis
Differences in the expression levels of target genes were identified by one-way ANOVA followed by the Fisher test (P < 0.05). When data that did not meet the normality and homoscedasticity assumptions, a Kruskal-Wallis one-way ANOVA on ranks was performed, with a Dunn's test for post hoc comparisons. In addition, a Spearman correlation Fig. 5 . Schematic representation of GC-induced skeletal muscle atrophy in L. guttatus. Stress triggers the release of glucocorticoids (GC), which bind to the glucocorticoid receptor (GR) in muscle cells. GR regulates transcription of FoxO3b, MuRf1 and myostatin. FoxO3b probably complex with Smad3 to activate murf1 transcription, activating in turn the ubiquitin-proteasome pathway for protein degradation. Myostatin binds the Activing IIB receptor (ActIIB-Alk4/5) to activate Smad2 and Smad3, both are transcription factors inhibiting mTOR signaling (Akt/TORC1), probably leading to the suppression of protein synthesis. In addition, Smad2 and 3 may target muscle regulatory factors (Myod-2 and myogenin) inhibiting myoblast and myofiber proliferation and differentiation. The dashed line indicates a possible relationship between myostatin and FoxO3b, since a significant correlation and a coordinated expression pattern was observed between both genes.
analysis was done to find associations in expression between different genes. All statistical analyses were performed with the SigmaPlot v11 software.
